Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-28 @ 7:23 AM
Study NCT ID:
NCT00057304
Status:
COMPLETED
Last Update Posted:
2023-04-28
First Post:
2003-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
ACTUAL
Primary Completion Date:
2004-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-03
Completion Date Type:
ACTUAL
First Submit Date:
2003-03-31
First Submit QC Date:
None
Study First Post Date:
2003-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-27
Last Update Post Date:
2023-04-28
Last Update Post Date Type:
ACTUAL